| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 01/20/1999 | EP0892059A2 Histidine kinase polypeptides |
| 01/20/1999 | EP0892057A2 Response regulator |
| 01/20/1999 | EP0892056A2 GidA1 polypeptides from Chlamydia trachomitis |
| 01/20/1999 | EP0892055A2 GidB polypeptides from Staphylococcus aureus |
| 01/20/1999 | EP0892053A2 production of recombinant HPMBQ91 polypeptide and uses thereof |
| 01/20/1999 | EP0892052A1 Sodium-bicarbonate transporter polypeptides |
| 01/20/1999 | EP0892051A2 CDNA Clone heoad54 that encodes a human 7 transmembrane receptor |
| 01/20/1999 | EP0892050A2 Human HFIZG53 |
| 01/20/1999 | EP0892049A2 A human pelota homolog |
| 01/20/1999 | EP0892047A2 Human and murine semaphorin L |
| 01/20/1999 | EP0891984A2 Nucleic acid encoding streptococcus pneumoniae response regulator |
| 01/20/1999 | EP0891983A1 Novel tarF |
| 01/20/1999 | EP0891780A2 Transfection systems, their preparation and application in Gentherapy |
| 01/20/1999 | EP0891429A2 Recombinant aav vector-based transduction system and use of same |
| 01/20/1999 | EP0891425A2 Methods and compositions for regulating t cell subsets by modulating transcription factor activity |
| 01/20/1999 | EP0891424A1 Human cachexia associated protein |
| 01/20/1999 | EP0891423A1 Genetic suppression and replacement |
| 01/20/1999 | EP0891374A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 01/20/1999 | EP0891372A1 Growth factor htter36 |
| 01/20/1999 | EP0891364A1 Calixpyrroles, calixpyridinopyrroles and calixpyridines |
| 01/20/1999 | EP0759986B1 Diagnostics for cancers expressing tyrosine phosphorylated crkl protein |
| 01/20/1999 | CN1205740A Diagnosis and treatment of Aur-1 and/or Aur-2 related disorders |
| 01/20/1999 | CN1205613A Hybrid matrix implants and explants |
| 01/19/1999 | US5861501 Capped synthetic RNA, analogs, and aptamers |
| 01/19/1999 | US5861497 Trabecular meshwork induced glucocorticoid response (TIGR) nucleic acid molecules |
| 01/19/1999 | US5861496 Nucleic acid and amino acid sequences of a novel squalene epoxidase and to the use of these sequences in the diagnosis, prevention, and treatment of diseases such as hypercholesterolemia and atherosclerosis. |
| 01/19/1999 | US5861493 Process for the synthesis of 2'-O-substituted pyrimidines |
| 01/19/1999 | US5861488 Gene therapy and gene expression of antisickling globulin proteins |
| 01/19/1999 | US5861397 Piperazine based cytofectins |
| 01/19/1999 | US5861381 Pharmaceutical composition for the treatment of a malignant tumor |
| 01/19/1999 | US5861314 Genetic manipulation which comprises a liposome comprised of lipid material, and adeno-associated viral (aav) material for genomes |
| 01/19/1999 | US5861312 Recognition component; hybridization; dna expression vectors; genetic engineering |
| 01/19/1999 | US5861307 Liposomes embedded with dna; antitumor agents; apotosis |
| 01/19/1999 | US5861298 Cathepsin K gene |
| 01/19/1999 | US5861290 Methods and polynucleotide constructs for treating host cells for infection or hyperproliferative disorders |
| 01/19/1999 | US5861281 Lacc |
| 01/19/1999 | US5861274 Nucleic acids encoding peroxisome proliferator-activated receptor |
| 01/19/1999 | US5861272 Antiasthmatic, antiallergen, and antiinflammatory agents;genetic engineering |
| 01/19/1999 | US5861266 Treatment of diabetes mellitus and insulin receptor signal transduction |
| 01/19/1999 | US5861259 Immunoassays for human cyclin E |
| 01/19/1999 | US5861248 Biomarkers for detection of prostate cancer |
| 01/19/1999 | US5861239 Treating cells having tub genes(body weight controllers) with test compounds to determine if they change the reactions of the tub protein; drug screening, obesity therapy |
| 01/19/1999 | US5861171 Adeno-associated viral (AAV) liposomes and methods related thereto |
| 01/19/1999 | US5861168 Vessels suffering vascular injury from angioplasty are treated with arginine or lysine to reduce probabilty of restenosis |
| 01/19/1999 | US5861161 Chimeric proteins comprising a Vpr/Vpx virion incorporation domain for targeting into HIV-1 or HIV-2 virions |
| 01/18/1999 | CA2237160A1 Gida1 |
| 01/18/1999 | CA2237147A1 Novel ratb |
| 01/18/1999 | CA2237143A1 Novel rata |
| 01/18/1999 | CA2237140A1 Novel tarf |
| 01/18/1999 | CA2237050A1 Histidine kinase |
| 01/18/1999 | CA2237043A1 Response regulator |
| 01/17/1999 | CA2237045A1 Novel glycogen phosphorylase |
| 01/16/1999 | CA2237784A1 Novel compounds |
| 01/15/1999 | CA2220849A1 A human pelota homolog |
| 01/14/1999 | WO1999001579A1 Compositions and methods for the delivery of oligonucleotides via the alimentary canal |
| 01/14/1999 | WO1999001574A1 Method for diagnosing alzheimer disease |
| 01/14/1999 | WO1999001553A1 Murine and human cerberus-like proteins and compositions comprising them |
| 01/14/1999 | WO1999001551A2 Novel inhibitor of cellular proliferation |
| 01/14/1999 | WO1999001549A1 Transcriptional activators with graded transactivation potential |
| 01/14/1999 | WO1999001465A1 A senescence gene and its use in the treatment of cancer and other diseases |
| 01/14/1999 | WO1999001175A1 Device for optimized electrotransfer of nucleic acid vectors to tissues in vivo |
| 01/14/1999 | WO1999001164A1 Cloning pigs using donor nuclei from differentiated cells |
| 01/14/1999 | WO1999001163A1 Cloning using donor nuclei from non-serum starved, differentiated cells |
| 01/14/1999 | WO1999001159A1 Lineage-restricted neuronal precursors |
| 01/14/1999 | WO1999001158A1 Improved method for transferring nucleic acid into the striped muscle and combination therefor |
| 01/14/1999 | WO1999001157A1 Improved method for transferring nucleic acid into multicelled eukaryotic organism cells and combination therefor |
| 01/14/1999 | WO1999001150A1 Novel composition for treating, preventing and/or delaying ischemic cell death |
| 01/14/1999 | WO1998044102A3 Methods of modulating p33ing1 mediated apoptosis |
| 01/14/1999 | WO1998044096A3 Mycobacterium recombinant vaccines |
| 01/14/1999 | WO1998040498A3 Immunoadhesins and methods of production and use thereof |
| 01/14/1999 | WO1998039466A3 Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof |
| 01/14/1999 | WO1998036067A3 Secreted proteins and polynucleotides encoding them |
| 01/14/1999 | WO1998035040A3 A single gene encoding aortic-specific and striated-specific muscle cell isoforms and uses thereof |
| 01/14/1999 | WO1998035020A3 Methods for modulating hematopoiesis and vascular growth |
| 01/14/1999 | WO1998034952A3 Il-2 gene expression and delivery systems and uses |
| 01/14/1999 | WO1998021333A3 Nucleic acid encoding schwannomin-binding-proteins and products related thereto |
| 01/14/1999 | DE19729211A1 New semaphorin L proteins |
| 01/14/1999 | CA2296105A1 Novel inhibitor of cellular proliferation |
| 01/14/1999 | CA2295294A1 Cloning pigs using donor nuclei from differentiated cells |
| 01/14/1999 | CA2295029A1 Device for optimized electrotransfer of nucleic acid vectors to tissues in vivo |
| 01/14/1999 | CA2294988A1 Compositions and methods for the delivery of oligonucleotides via the alimentary canal |
| 01/14/1999 | CA2294916A1 Cloning using donor nuclei from non-serum starved, differentiated cells |
| 01/14/1999 | CA2294802A1 Improved method for transferring nucleic acid into multicelled eukaryotic organism cells and combination therefor |
| 01/14/1999 | CA2294793A1 Improved method for transferring nucleic acid into the striped muscle and combination therefor |
| 01/14/1999 | CA2294737A1 Lineage-restricted neuronal precursors |
| 01/14/1999 | CA2236489A1 Novel compounds |
| 01/13/1999 | EP0890647A2 PcrA, novel polypeptide of the DNA helicases family |
| 01/13/1999 | EP0890644A2 MurA gene from Staphylococcus aureus encoding DP-N-Acetylglucosamine enolpyruvyl transferase |
| 01/13/1999 | EP0890641A1 Novel IspA |
| 01/13/1999 | EP0890639A2 BMP2-induced cDNA and its use |
| 01/13/1999 | EP0890362A1 Compositions useful for transferring therapeutically active substances into a target cell, and their use in gene therapy |
| 01/13/1999 | EP0889969A1 Recombinant adenoviral vectors for human tumour gene therapy |
| 01/13/1999 | EP0889968A2 Psa positive regulating (psar) sequences and uses thereof |
| 01/13/1999 | EP0889731A1 Injectable therapy for control of muscle spasms and pain related to muscle spasms |
| 01/12/1999 | US5859310 Mice transgenic for a tetracycline-controlled transcriptional activator |
| 01/12/1999 | US5859309 Vector for integration site independent gene expression in mammalian host cells |
| 01/12/1999 | US5859229 For inhibition of gene expression of human cyclooxygenase 2 by binding to specific untranslated regions of messenger rna; treatment of premature labor, preeclampsia, endometriosis, rheumatoid arthritis |
| 01/12/1999 | US5859221 Hybrid dna, rna; nuclease resistant |
| 01/12/1999 | US5859201 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 01/12/1999 | US5858981 Modulating the clearance of antibody-coated cells from circulation; modulating the interaction of immune complexes with tissue fc receptors; modulating the activation of immunological processes |